| Dr Judith Hauck, DNP, RN, PMHCNS-BC | |
|
3 Enck Cir, Enola, PA 17025-1050 | |
| (717) 576-9243 | |
| (866) 683-4434 |
| Full Name | Dr Judith Hauck |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Adult |
| Location | 3 Enck Cir, Enola, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972620094 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0809X | Clinical Nurse Specialist - Psychiatric/mental Health, Adult | RN195926L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Judith Hauck, DNP, RN, PMHCNS-BC 3 Enck Cir, Enola, PA 17025-1050 Ph: (717) 576-9243 | Dr Judith Hauck, DNP, RN, PMHCNS-BC 3 Enck Cir, Enola, PA 17025-1050 Ph: (717) 576-9243 |
News Archive
Scientists from Bochum have managed to accurately determine the location of metal complexes within living cancer cells using Raman microscopy. The researchers have thus gained new insights into the mechanism of action of metal-containing drugs, to which they ascribe great potential capacities, e.g. in the treatment of cancer.
One out of ten E. coli samples contained variants that are resistant to several kinds of antibiotics, a new analysis on Norwegian blood samples revealed. The proportion of multi-resistant E. coli bacteria doubled from 2002-2009 to 2010-2017.
A comprehensive health promotion program reduced cardiovascular disease-related medical and hospital costs, according to a new study. CSX Transportation, a national company with 30,000 employees, developed the program in 2004 to address employees' high rates of cardiovascular disease when compared to national benchmarks and the associated higher healthcare costs.
Today, Merck announced that Health Canada has extended the indication of GARDASIL in women up to the age of 45. Merck's HPV vaccine is now approved for girls and women nine through 45 years of age for the prevention of cervical cancer, vulvar and vaginal cancers, precancerous lesions and genital warts caused by the Human Papillomavirus types 6, 11, 16, 18. Previously, GARDASIL was approved in girls and women nine through 26.
The Senate Finance Committee will delay its vote on health care reform — and, likely the bill's move to the Senate floor — as members await cost estimates by the Congressional Budget Office.
› Verified 9 days ago